# Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression

**Authors:** Zhi‐Mei Li, Guan Liu, Qing‐Qing Liu, Wei‐Ming You, Ming‐Gao Zhao

PMC · DOI: 10.1002/ctm2.70366 · 2025-06-09

## Full-text entities

- **Genes:** FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}
- **Diseases:** hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** daunorubicin (MESH:D003630)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12148948/full.md

---
Source: https://tomesphere.com/paper/PMC12148948